2013
DOI: 10.1016/j.mri.2012.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Rapid sequential injections of hyperpolarized [1-13C]pyruvate in vivo using a sub-kelvin, multi-sample DNP polarizer

Abstract: The development of hyperpolarized technology utilizing dynamic nuclear polarization (DNP) has enabled the rapid measurement of 13C metabolism in vivo with very high SNR. However, with traditional DNP equipment, consecutive injections of a hyperpolarized compound in an animal have been subject to a practical minimum time between injections governed by the polarization build-up time, which is on the order of an hour for [1-13C]pyruvate. This has precluded the monitoring of metabolic changes occurring on a faster… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
51
0

Year Published

2013
2013
2018
2018

Publication Types

Select...
7
1

Relationship

5
3

Authors

Journals

citations
Cited by 38 publications
(52 citation statements)
references
References 13 publications
(22 reference statements)
1
51
0
Order By: Relevance
“…Lactate and alanine production was also found in rat liver (data not shown). These outcomes were highly consistent with the previous observations on HP‐ 13 C rat studies …”
Section: Resultssupporting
confidence: 93%
“…Lactate and alanine production was also found in rat liver (data not shown). These outcomes were highly consistent with the previous observations on HP‐ 13 C rat studies …”
Section: Resultssupporting
confidence: 93%
“…[ 13 C, 15 N 2 ]Urea (Sigma Aldrich) was dissolved in glycerol and mixed with 15 mM trityl radical OX063 (Oxford Instruments, Abingdon, UK) and 1.5 mM Gd-DOTA. Each compound was individually polarized in either a HyperSense dissolution DNP system (Oxford Instruments, Abingdon, UK) operating at 1.35 K and 3.35 T (lactic acid [41] and urea [22]) for ~1hr or a SpinLab (GE Healthcare, Waukesha, WI), operating at 0.8K and 3.35T (pyruvic acids [42]) for ~2hrs to achieve polarizations of 20–25% (urea and lactate) to 30–35% (pyruvic acids). The dissolution media and resulting concentration for each compound was as follows: 4.5 mL of 80 mM NaOH/40 mM Tris buffer for [1- 13 C]pyruvic acid resulting in 80 mM [1- 13 C]pyruvate (hereafter referred to as C 1 -pyruvate); 4.5 mL of 80 mM NaOH/40 mM Tris buffer for [2- 13 C]pyruvic acid resulting in 80 mM [2- 13 C]pyruvate (hereafter referred to as C 2 -pyruvate); 4.5 mL of 160 mM NaOH/40 mM Tris buffer for [1- 13 C]lactic acid resulting in 160 mM [1- 13 C]lactate (hereafter referred to as lactate); 5mL of 1x phosphate-buffered saline for [ 13 C, 15 N 2 ]urea resulting in 110 mM [ 13 C, 15 N 2 ]urea (hereafter referred to as urea).…”
Section: Methodsmentioning
confidence: 99%
“…The hyperpolarized [1‐ 13 C]‐pyruvate was produced using either a prototype SpinLab (General Electric, Niskayuna, New York, USA) or a HyperSense (Oxford Instruments, Abingdon, UK) DNP polarizer. For the SpinLab system, a mixture consisting of 1,000 μL (∼1,280 mg) of C1‐labeled pyruvic acid and 15 mM trityl radical was polarized.…”
Section: Methodsmentioning
confidence: 99%